Betaine protects against rotenone-induced neurotoxicity in PC12 cells

Cellular and Molecular Neurobiology

Volumn 33, Issue 5, 2013, Pages 625-635

  Im, A Rang ^a   Kim, Young Hwa ^a   Uddin, Md Romij ^a   Chae, Sungwook ^a   Lee, Hye Won ^a   Kim, Yun Hee ^a   Kim, Yeong Shik ^b   Lee, Mi Young ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Apoptosis; Betaine; Mitochondrial dysfunction; Neuroprotection; Rotenone

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETAINE; CASPASE 3; CASPASE 7; CASPASE 9; REACTIVE OXYGEN METABOLITE; ROTENONE; CASPASE; NEUROPROTECTIVE AGENT; NEUROTOXIN; SUPEROXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; FLOW CYTOMETRY; MITOCHONDRIAL MEMBRANE DEPOLARIZATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; CONFOCAL MICROSCOPY; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NICK END LABELING; PC12 CELL LINE; RAT; TOXICITY;

ANIMALS; BETAINE; CASPASES; ENERGY METABOLISM; ENZYME ACTIVATION; FLOW CYTOMETRY; IN SITU NICK-END LABELING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PC12 CELLS; RATS; ROTENONE; SUPEROXIDES;

EID: 84878718707     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9921-z     Document Type: Article

References (28)

1. Batandier C, Fontaine E, Keriel C, Leverve XM (2002) Determination of mitochondrial reactive oxygen species: methodological aspects. J Cell Mol Med 6:175-187
2. Bidulescu A, Chambless LE, Siega-Riz AM, Zeisel SH, Heiss G (2007) Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord 7:20
3. Caserta MT, Bannon Y, Fernandez F, Giunta B, Schoenberg MR, Tan J (2009) Chapter 1 Normal brain aging: clinical, immunological, neuropsychological, and neuroimaging features. Int Rev Neurobiol 84:1-19
4. Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C (2007) Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 18:184-195
5. Craig SA (2004) Betaine in human nutrition. Am J Clin Nutr 80:539-549
6. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909
7. Du YP, Peng JS, Sun A, Tang ZH, Ling WH, Zhu HL (2009) Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model. BMC Cancer 9:261
8. Fukae J, Mizuno Y, Hattori N (2007) Mitochondrial dysfunction in Parkinson's disease. Mitochondrion 7:58-62
9. Ganesan B, Anandan R (2009) Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats. Cell Stress Chaperones 14:661-667
10. Ganesan B, Anandan R, Lakshmanan PT (2011) Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats. Cell Stress Chaperones 16:641-652
11. Ho YS, So KF, Chang RC (2010) Anti-aging herbal medicine-how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev 9:354-362
12. Kanbak G, Inal M, Baycu C (2001) Ethanol-induced hepatotoxicity and protective effect of betaine. Cell Biochem Funct 19:281-285
13. Keane PC, Kurzawa M, Blain PG, Morris CM (2011) Mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis 2011:716871
14. Kirkinezos IG, Moraes CT (2001) Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12:449-457
15. Martin LJ (2010) Mitochondrial and cell death mechanisms in neurodegenerative diseases. Pharmaceuticals (Basel) 3:839-915
16. Mehler MF, Gokhan S (2000) Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat. Trends Neurosci 23:599-605
17. Moran M, Rivera H, Sanchez-Arago M, Blazquez A, Merinero B, Ugalde C, Arenas J, Cuezva JM, Martin MA (2010) Mitochondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts. Biochim Biophys Acta 802:443-453
18. Pettmann B, Henderson CE (1998) Neuronal cell death. Neuron 20:633-647
19. Petty RD, Sutherland LA, Hunter EM, Cree IA (1995) Comparison of MTT and ATP based assays for the measurement of viable cell number. J Biolumin Chemilumin 10:29-34
20. Ribe EM, Serrano-Saiz E, Akpan N, Troy CM (2008) Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 415:165-182
21. Riederer BM, Leuba G, Vernay A, Riederer IM (2011) The role of the ubiquitin proteasome system in Alzheimer's disease. Exp Biol Med (Maywood) 236:268-276
22. Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik NL (2007) The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146:741-755
23. Shin YG, Cho KH, Kim JM, Park MK, Park JH (1999) Determination of betaine in Lycium chinense fruits by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr A 857:331-335
24. Tenenbaum L, Chtarto A, Lehtonen E, Blum D, Baekelandt V, Velu T, Brotchi J, Levivier M (2002) Neuroprotective gene therapy for Parkinson's disease. Curr Gene Ther 2:451-483
25. Velier JJ, Ellison JA, Kikly KK, Spera PA, Barone FC, Feuerstein GZ (1999) Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci 19:5932-5941
26. Vila M, Ramonet D, Perier C (2008) Mitochondrial alterations in Parkinson's disease: new clues. J Neurochem 107:317-328
27. Wei HL, Jiafeng S, Ming C, Hongyan C, Linsen H (2008) Mechanisms of rotenone-induced neurotoxicity in PC 12 cells. Neural Regen Res 3:1281-1285
28. Weir HJ, Murray TK, Kehoe PG, Love S, Verdin EM, O'Neill MJ, Lane JD, Balthasar N (2012) CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. PLoS One 7:e48225